Bahrain Approves Sinopharm Vaccine for Children 3 to 11

Bahrain 's National Medical Taskforce for Combatting the Coronavirus has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years, from October 27.

It also added that the Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11.

Sinopharm vaccine approved for all children aged 3 to 11https://t.co/AwEJ2fBddb

— Bahrain News Agency (@bna_en) October 26, 2021

The Taskforce stressed that it is important that eligible children get vaccinated to protect themselves, their families, and public health.

Parents can register their children through the Ministry of Health's website or through the BeAware application.

Registration requires the consent of a legal guardian and an adult must accompany the child when receiving the vaccine.